{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:19:45Z","timestamp":1782253185931,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1574,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jacc.2009.01.054","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T08:13:57Z","timestamp":1241079237000},"page":"1660-1667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus"],"prefix":"10.1016","volume":"53","author":[{"given":"Ole","family":"Fr\u00f6bert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lagerqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lindb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Stenestrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.01.054_bib1","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0735-1097(98)00467-7","article-title":"Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement","volume":"32","author":"Elezi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8183.2002.tb01025.x","article-title":"Predictors of clinical outcome following NIR stent implantation for coronary artery disease: analysis of the results of the First International New Intravascular Rigid-Flex Endovascular Stent Study (FINESS trial)","volume":"15","author":"Feld","year":"2002","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2007.10.035","article-title":"Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials","volume":"51","author":"Kirtane","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib4","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.105.562421","article-title":"Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial","volume":"112","author":"Sabate","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.01.054_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.107.730416","article-title":"Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry","volume":"117","author":"Ortolani","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.01.054_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2337\/dc07-1377","article-title":"Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study","volume":"31","author":"Tomai","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2009.01.054_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn021","article-title":"Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients","volume":"29","author":"Billinger","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.01.054_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.01.054_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjcard.2006.01.074","article-title":"Sirolimus-eluting stents versus paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus","volume":"98","author":"Kuchulakanti","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib10","doi-asserted-by":"crossref","first-page":"56M","DOI":"10.1016\/j.amjcard.2007.08.023","article-title":"Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study","volume":"100","author":"Meredith","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jacc.2007.07.035","article-title":"One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients","volume":"50","author":"Baumgart","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.amjcard.2005.03.075","article-title":"Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)","volume":"96","author":"Ong","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.amjcard.2006.01.104","article-title":"Impact of sirolimus-eluting and paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery","volume":"98","author":"Stankovic","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib14","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.jacc.2008.03.028","article-title":"Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis","volume":"51","author":"Mahmud","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.01.054_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709005440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709005440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:31:49Z","timestamp":1760013109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709005440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0735109709005440"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.01.054","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}